Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

18.09
Delayed Data
As of Jul 31
 -0.09 / -0.50%
Today’s Change
15.56
Today|||52-Week Range
20.60
+9.90%
Year-to-Date
VIVO Regular Dividend: VIVO began trading ex-dividend on 07/30/15. A $0.20 dividend will be paid to shareholders of record as of 08/03/15.

Today’s Trading

Previous close18.18
Today’s open18.26
Day’s range18.01 - 18.37
Volume140,272
Average volume (3 months)252,842
Market cap$758.4M
Dividend yield4.42%
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-8.79%
Earnings growth (this year)+3.61%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+0.08%
P/E ratio21.6
Price/Sales3.93
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.25-1.19%
GHDXGenomic Health Inc+0.74+2.81%
GERNGeron Corp-0.08-1.94%
NTRANatera Inc-0.04-0.22%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)$0.21
Annual revenue (last year)$188.8M
Annual profit (last year)$34.7M
Net profit margin18.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John A. Kraeutler
Executive VP-Operations &
Information Systems
Lawrence J. Baldini
Corporate headquarters
Cincinnati, Ohio

Forecasts